{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:10:55Z","timestamp":1759104655098,"version":"3.44.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ijcard.2023.04.057","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T11:38:27Z","timestamp":1683200307000},"page":"75-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The effect of antithrombotic treatment on mortality in patients with acute infection: A meta-analysis of randomized clinical trials"],"prefix":"10.1016","volume":"383","author":[{"given":"Gianluca","family":"Gazzaniga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni Amedeo","family":"Tavecchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Bravi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Scavelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Travi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Campo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Vandenbriele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Tritschler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan A.C.","family":"Sterne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Srinivas","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuccia","family":"Morici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ijcard.2023.04.057_bb0005","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41569-021-00552-1","article-title":"Interplay between inflammation and thrombosis in cardiovascular pathology","volume":"18","author":"Stark","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2023.04.057_bb0010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nri3345","article-title":"Thrombosis as an intravascular effector of innate immunity","volume":"13","author":"Engelmann","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.ijcard.2023.04.057_bb0015","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nm.2184","article-title":"Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases","volume":"16","author":"Massberg","year":"2010","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.ijcard.2023.04.057_bb0020","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13613-017-0339-5","article-title":"Immunohaemostasis: a new view on haemostasis during sepsis","volume":"7","author":"Delabranche","year":"2017","journal-title":"Ann. Intensive Care"},{"issue":"2","key":"10.1016\/j.ijcard.2023.04.057_bb0025","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/15412555.2013.831062","article-title":"Efficacy of low molecular weight heparin in patients with acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support","volume":"11","author":"Qian","year":"2014","journal-title":"COPD"},{"key":"10.1016\/j.ijcard.2023.04.057_bb0030","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jss.2019.01.020","article-title":"Unfractionated heparin alleviates Sepsis-induced acute lung injury by protecting tight junctions","volume":"238","author":"Liu","year":"2019","journal-title":"J. Surg. Res."},{"issue":"2","key":"10.1016\/j.ijcard.2023.04.057_bb0035","first-page":"117","article-title":"Unfractionated heparin inhibits lipopolysaccharide-induced expression of chemokines in human endothelial cells through nuclear factor-\u039aB signaling pathway","volume":"28","author":"Li","year":"2016","journal-title":"Zhonghua Wei Zhong Bing Ji Jiu Yi Xue"},{"issue":"1","key":"10.1016\/j.ijcard.2023.04.057_bb0040","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1124\/pr.115.011247","article-title":"Pharmacology of heparin and related drugs","volume":"68","author":"Mulloy","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ijcard.2023.04.057_bb0045","article-title":"The use of the anticoagulant heparin and corticosteroid dexamethasone as prominent treatments for COVID-19","volume":"8","author":"Braz-de-Melo","year":"2021","journal-title":"Front. Med. (Lausanne)"},{"key":"10.1016\/j.ijcard.2023.04.057_bb0050","article-title":"The 2019 coronavirus (SARS-CoV-2) surface protein (Spike) S1 Receptor Binding Domain undergoes conformational change upon heparin binding [Internet]","author":"Mycroft-West","year":"2020","journal-title":"bioRxiv"},{"issue":"4","key":"10.1016\/j.ijcard.2023.04.057_bb0055","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.cell.2020.09.033","article-title":"SARS-CoV-2 infection depends on cellular Heparan sulfate and ACE2","volume":"183","author":"Clausen","year":"2020","journal-title":"Cell."},{"issue":"1","key":"10.1016\/j.ijcard.2023.04.057_bb0060","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1186\/s13054-020-03148-2","article-title":"Nebulised heparin as a treatment for COVID-19: scientific rationale and a call for randomised evidence","volume":"24","author":"van Haren","year":"2020","journal-title":"Crit. Care"},{"issue":"11","key":"10.1016\/j.ijcard.2023.04.057_bb0065","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1038\/s41379-020-0595-z","article-title":"In situ detection of SARS-CoV-2 in lungs and airways of patients with COVID-19","volume":"33","author":"Schaefer","year":"2020","journal-title":"Mod. Pathol."},{"issue":"6","key":"10.1016\/j.ijcard.2023.04.057_bb0070","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/cts.12880","article-title":"The potential of low molecular weight heparin to mitigate cytokine storm in severe COVID-19 patients: a retrospective cohort study","volume":"13","author":"Shi","year":"2020","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.ijcard.2023.04.057_bb0075","first-page":"CD013739","article-title":"Prophylactic anticoagulants for people hospitalised with COVID-19","volume":"10","author":"Flumignan","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.ijcard.2023.04.057_bb0080","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ."},{"author":"20190822_RoB_2.0_guidance_parallel_trial.pdf [Internet]","key":"10.1016\/j.ijcard.2023.04.057_bb0085"},{"key":"10.1016\/j.ijcard.2023.04.057_bb0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/oxfordjournals.epirev.a036298","article-title":"Quantitative methods in the review of epidemiologic literature","volume":"9","author":"Greenland","year":"1987","journal-title":"Epidemiol. Rev."},{"issue":"11","key":"10.1016\/j.ijcard.2023.04.057_bb0095","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"issue":"2","key":"10.1016\/j.ijcard.2023.04.057_bb0100","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0895-4356(99)00161-4","article-title":"Publication bias in meta-analysis: its causes and consequences","volume":"53","author":"Thornton","year":"2000","journal-title":"J. Clin. Epidemiol."},{"issue":"7109","key":"10.1016\/j.ijcard.2023.04.057_bb0105","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ."},{"issue":"3","key":"10.1016\/j.ijcard.2023.04.057_bb0110","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1378\/chest.104.3.882","article-title":"Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation","volume":"104","author":"Fourrier","year":"1993","journal-title":"Chest."},{"issue":"9012","key":"10.1016\/j.ijcard.2023.04.057_bb0115","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(96)91009-0","article-title":"Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patients with infectious diseases. The Heparin Prophylaxis Study Group","volume":"347","author":"G\u00e4rdlund","year":"1996","journal-title":"Lancet."},{"issue":"4","key":"10.1016\/j.ijcard.2023.04.057_bb0120","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s001340050576","article-title":"Antithrombin III (ATIII) replacement therapy in patients with sepsis and\/or postsurgical complications: a controlled double-blind, randomized, multicenter study","volume":"24","author":"Baudo","year":"1998","journal-title":"Intensive Care Med."},{"issue":"7","key":"10.1016\/j.ijcard.2023.04.057_bb0125","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s001340050642","article-title":"Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis","volume":"24","author":"Eisele","year":"1998","journal-title":"Intensive Care Med."},{"issue":"4","key":"10.1016\/j.ijcard.2023.04.057_bb0130","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1046\/j.1365-2362.2000.00630.x","article-title":"Antithrombin III and local serum application: adjuvant therapy in peritonitis","volume":"30","author":"Schorr","year":"2000","journal-title":"Eur. J. Clin. Investig."},{"issue":"11","key":"10.1016\/j.ijcard.2023.04.057_bb0135","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1097\/00003246-200111000-00007","article-title":"Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study","volume":"29","author":"Abraham","year":"2001","journal-title":"Crit. Care Med."},{"issue":"15","key":"10.1016\/j.ijcard.2023.04.057_bb0140","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1001\/jama.286.15.1869","article-title":"High-dose Antithrombin III in severe SepsisA randomized controlled trial","volume":"286","author":"Warren","year":"2001","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.ijcard.2023.04.057_bb0145","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0735-1097(03)00829-5","article-title":"A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis","volume":"42","author":"Chan","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2023.04.057_bb0150","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/CCM.0b013e31819c06bc","article-title":"Unfractioned heparin for treatment of sepsis: a randomized clinical trial (the HETRASE study)","volume":"37","author":"Jaimes","year":"2009","journal-title":"Crit. Care Med."},{"issue":"1\u20132","key":"10.1016\/j.ijcard.2023.04.057_bb0155","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jns.2010.03.025","article-title":"Role of aspirin in tuberculous meningitis: a randomized open label placebo controlled trial","volume":"293","author":"Misra","year":"2010","journal-title":"J. Neurol. Sci."},{"issue":"4","key":"10.1016\/j.ijcard.2023.04.057_bb0160","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/SHK.0b013e318204c019","article-title":"Thrombomodulin alfa in the treatment of infectious patients complicated by disseminated intravascular coagulation: subanalysis from the phase 3 trial","volume":"35","author":"Aikawa","year":"2011","journal-title":"Shock."},{"issue":"3","key":"10.1016\/j.ijcard.2023.04.057_bb0165","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/MCA.0b013e32835d7610","article-title":"Does aspirin use prevent acute coronary syndrome in patients with pneumonia: multicenter prospective randomized trial","volume":"24","author":"Oz","year":"2013","journal-title":"Coron. Artery Dis."},{"issue":"3","key":"10.1016\/j.ijcard.2023.04.057_bb0170","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cjtee.2015.04.003","article-title":"Comparison of fondaparinux sodium and low molecular weight heparin in the treatment of hypercoagulability secondary to traumatic infection","volume":"18","author":"Li","year":"2015","journal-title":"Chin. J. Traumatol."},{"issue":"12","key":"10.1016\/j.ijcard.2023.04.057_bb0175","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012850","article-title":"Can recombinant human thrombomodulin increase survival among patients with severe septic-induced disseminated intravascular coagulation: a single-Centre, open-label, randomised controlled trial","volume":"6","author":"Hagiwara","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijcard.2023.04.057_bb0180","series-title":"Impacts of early anticoagulant therapy on tissue perfusion in patients with sepsis","first-page":"20074","volume":"9","author":"Yang","year":"2016"},{"key":"10.1016\/j.ijcard.2023.04.057_bb0185","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.33478","article-title":"A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults","volume":"7","author":"Mai","year":"2018","journal-title":"Elife."},{"issue":"5","key":"10.1016\/j.ijcard.2023.04.057_bb0190","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1055\/s-0038-1639586","article-title":"Targeting coagulase activity in Staphylococcus aureus Bacteraemia: a randomized controlled single-Centre trial of Staphylothrombin inhibition","volume":"118","author":"Peetermans","year":"2018","journal-title":"Thromb. Haemost."},{"issue":"20","key":"10.1016\/j.ijcard.2023.04.057_bb0195","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2019.5358","article-title":"Effect of a recombinant human soluble Thrombomodulin on mortality in patients with Sepsis-associated coagulopathy: the SCARLET randomized clinical trial","volume":"321","author":"Vincent","year":"2019","journal-title":"JAMA."},{"key":"10.1016\/j.ijcard.2023.04.057_bb0200","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.3389\/fimmu.2019.02400","article-title":"Platelets and intravascular immunity: guardians of the vascular space during bloodstream infections and Sepsis","volume":"10","author":"McDonald","year":"2019","journal-title":"Front. Immunol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527323006460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527323006460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T21:02:02Z","timestamp":1759093322000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527323006460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":40,"alternative-id":["S0167527323006460"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2023.04.057","relation":{},"ISSN":["0167-5273"],"issn-type":[{"type":"print","value":"0167-5273"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of antithrombotic treatment on mortality in patients with acute infection: A meta-analysis of randomized clinical trials","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2023.04.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}